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Myosin binding protein-C (MyBP-C) is a key regulatory protein in
heart muscle, and mutations in the MYBPC3 gene are frequently
associated with cardiomyopathy. However, the mechanism of
action of MyBP-C remains poorly understood, and both activating
and inhibitory effects of MyBP-C on contractility have been
reported. To clarify the function of the regulatory N-terminal
domains of MyBP-C, we determined their effects on the structure
of thick (myosin-containing) and thin (actin-containing) filaments
in intact sarcomeres of heart muscle. We used fluorescent probes
on troponin C in the thin filaments and on myosin regulatory light
chain in the thick filaments to monitor structural changes associ-
ated with activation of demembranated trabeculae from rat
ventricle by the C1mC2 region of rat MyBP-C. C1mC2 induced
larger structural changes in thin filaments than calcium activation,
and these were still present when active force was blocked with
blebbistatin, showing that C1mC2 directly activates the thin
filaments. In contrast, structural changes in thick filaments induced
by C1mC2 were smaller than those associated with calcium
activation and were abolished or reversed by blebbistatin. Low
concentrations of C1mC2 did not affect resting force but increased
calcium sensitivity and reduced cooperativity of force and struc-
tural changes in both thin and thick filaments. These results show
that the N-terminal region of MyBP-C stabilizes the ON state of
thin filaments and the OFF state of thick filaments and lead to
a novel hypothesis for the physiological role of MyBP-C in the
regulation of cardiac contractility.
cardiac muscle regulation | myosin-binding protein-C | MYBPC3
Muscle contraction is driven by the relative sliding of theactin-containing thin filaments along the myosin-containing
thick filaments arranged in a parallel array in the muscle sar-
comere (Fig. 1A). Filament sliding in turn is driven by a structural
change in the myosin head domains (Fig. 1B) while they are bound
to actin, coupled to the hydrolysis of ATP (1). Contraction of
skeletal and cardiac muscle is triggered by calcium binding to
troponin in the thin filaments, accompanied by a change in the
structure of the thin filaments that permits myosin head binding
(2). However, the strength and dynamics of contraction are
modulated by posttranslational modifications in other sarcomeric
proteins, including the myosin regulatory light chain (RLC) (3),
which is part of the myosin head, and myosin binding protein-C
(4–6) (MyBP-C) (Fig. 1B). In an emerging concept of thick fila-
ment regulation in striated muscle that is analogous to myosin-
linked regulation in smooth muscle (7–11), RLC and MyBP-C are
thought to modulate contraction by controlling the conformation
of the myosin heads.
According to this concept, the thick filament has an OFF state
in which the myosin heads are folded back against its surface (Fig.
1B), rendering them unavailable for interaction with actin, and an
ON state in which the heads are released from the thick filament
surface and made available for actin binding. The physiological
and pathological significance of thick filament regulation and its
relationship to the well-studied thin filament mechanisms remain
poorly understood, but much recent attention has focused on
MyBP-C for two main reasons. First, mutations in the cardiac
MYBPC3 gene are commonly associated with hypertrophic car-
diomyopathy (12, 13), and this association has driven a wide range
of studies at the molecular, cellular, and whole-animal levels
aimed at understanding the etiology of MYBPC3-linked disease.
Second, although MyBP-C is a constitutive component of the thick
filament, there is a large body of evidence that it can also bind the
thin filaments (14, 15), raising the possibility that one role of
MyBP-C may be to synchronize the regulatory states of the thin
and thick filaments (11, 15–17).
MyBP-C is localized to the central region or “C-zone” of each
half-thick filament (Fig. 1A), appearing in nine transverse stripes
with a 43-nm periodicity closely matching that of the myosin
heads (Fig. 1B) (10). MyBP-C has 11 Ig-like or fibronectin-like
domains (Fig. 1C) denoted C0–C10, with additional linking
sequences, notably the MyBP-C “motif” or “m” domain between
C1 and C2 and the proline/alanine-rich (P/A) linker between C0
and C1. The m domain has multiple phosphorylation sites (4–6).
Constitutive binding to the thick filament is mediated by inter-
actions of domains C8–C10 with myosin and titin. The C1mC2
region binds to the coiled-coil subfragment-2 (S2) domain of
myosin adjacent to the myosin heads, and this interaction is
abolished by MyBP-C phosphorylation (5); the C0 domain binds
to the RLC in the myosin head itself (18). The N-terminal
domains of MyBP-C also bind to actin in a phosphorylation-
dependent manner (14, 15) (Fig. 1B), and EM and X-ray studies
on intact sarcomeres of skeletal muscle suggest that MyBP-C
binds to thin filaments under relaxing conditions (10, 11).
The function of MyBP-C and the mechanisms underlying its
modulation in cardiomyopathy remain poorly understood, how-
ever. Ablation of MyBP-C in a knockout mouse model leads to
a hypertrophic phenotype associated with impaired contractile
function (19), but cardiomyocytes isolated from these mice
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exhibit increased power output during working contractions (20).
A range of studies at the isolated protein and cellular levels have
led to the concept that MyBP-C exerts a predominantly in-
hibitory effect on contractility mediated through two distinct
mechanisms (15, 16, 21). MyBP-C may tether myosin heads to the
surface of the thick filament, preventing their interaction with
actin, and its N terminus may bind to thin filaments, inhibiting
interfilament sliding at low load. Other studies, however, have
demonstrated an activating effect of MyBP-C mediated by binding
of its N-terminal domains to the thin filament. N-terminal frag-
ments of MyBP-C enhance force production in skinned cardiac
muscle cells and motility in isolated filament preparations at zero
or submaximal calcium concentrations (22–25). The same effect is
observed in cardiomyocytes from MyBP-C knockout mice (22),
suggesting that the activating effect is not due to competitive re-
moval of an inhibitory effect of native MyBP-C.
To resolve these apparently contradictory hypotheses about
the physiological function of the N-terminal domains of MyBP-C,
we determined the structural changes in the thick and thin fil-
aments of intact sarcomeres in heart muscle cells induced by
N-terminal MyBP-C fragments using bifunctional rhodamine
probes on RLC and troponin C (TnC) (26). These probes
allowed the structural changes in both types of filament to be
directly compared with those associated with calcium activation
and myosin head binding in the native environment of the car-
diac muscle sarcomere. The results lead to a model for the
physiological function of MyBP-C that integrates the regulatory
roles of the thin and thick filaments and the inhibitory and ac-
tivating effects of MyBP-C at the level of the intact sarcomere.
Results
Activation of Rat Ventricular Trabeculae by Rat MyBP-C Fragments.
Rat MyBP-C fragments containing the N-terminal sequence
from domains C0–C2 (C0C2) activated contraction in skinned
ventricular trabeculae of the rat in the absence of calcium (SI
Appendix, Fig. S2A). A shorter fragment containing only domains
C1 and C2 and the intervening m-motif (C1mC2) had a similar
effect. The C0C1 fragment, the isolated m-motif, and a C1×C2
construct in which the m-motif was replaced by a flexible linker
(GGGGS)5, did not activate at concentrations up to 50 μmol/L
(SI Appendix, Figs. S2A and S3). The C1mC2 construct from the
MyBP-C isoform from fast skeletal muscle also did not activate
rat trabeculae (SI Appendix, Fig. S4A), but a chimera containing
the cardiac C1 and C2 sequences linked by the m-motif from fast
skeletal muscle had the same activating effect as cardiac C1mC2
(SI Appendix, Fig. S4B). Thus, for rat MyBP-C fragments in rat
ventricular trabeculae, the C1mC2 region is sufficient for acti-
vation of contraction, and the C0 domain and the P/A linker
between C0 and C1 are not required. Tris-phosphorylation of
C1mC2 by PKA abolished the activating effect (SI Appendix, Fig.
S2A). We therefore used the unphosphorylated C1mC2 frag-
ment for all of the experiments described below.
Active isometric force produced by the addition of C1mC2 in
relaxing solution had a sigmoidal dependence on C1mC2 con-
centration, with an EC50 of 20 ± 2 μmol/L (mean ± SEM, n = 4)
(SI Appendix, Fig. S2B). Maximum force was about 60% of that
produced by calcium activation at pCa 4.5 in the absence of the
fragment (T0). In the presence of 50 μmol/L C1mC2, isometric
force was the same in the absence (pCa 9) and the presence
(pCa 4.5) of calcium [T/T0 = 56 ± 4% (mean ± SEM, n = 9) and
56 ± 6%, respectively; SI Appendix, Fig. S2B]. Therefore, al-
though 50 μmol/L C1mC2 activates contraction in the absence of
calcium, it inhibits active force in the presence of calcium. These
results are broadly consistent with the reported effects of mouse
MyBP-C fragments in skinned rat trabeculae (25), but differ
from those of studies using human MyBP-C fragments in human
or mouse cardiomyocytes (23) in which the P/A linker region
flanked by domains C0 and C1 was required for activation in the
absence of calcium. The comparison suggests a functional dif-
ference between human and rodent MyBP-C (27) or possibly
between cardiomyocytes and trabeculae. The former explanation
seems the more likely because rodent and human MyBP-C have
roughly 90% sequence identity in the m-motif, but only 36–58%
in the P/A linker (28).
C1mC2 Directly Activates Thin Filaments in the Absence of Calcium.
We used site-specific bifunctional rhodamine (BR) probes on
TnC to monitor changes in the structure of the thin filaments
during activation of cardiac muscle by C1mC2. A BR probe on
the C-helix of TnC (BR-TnC-C) was used to monitor the ori-
entation of its N-terminal domain containing the regulatory Ca2+
site (29). A probe on the E-helix of TnC (BR-TnC-E) was used
to monitor the orientation of the elongated “IT arm” domain of
troponin that also contains segments of troponin I (TnI) and
troponin T (TnT) (30). The E-helix probe monitors a step in the
thin filament signaling pathway that is closely coupled to the
azimuthal movement of tropomyosin that uncovers the myosin-
binding sites on actin during Ca2+-mediated activation (29).
BR-TnC-C or BR-TnC-E was introduced into skinned ven-
tricular trabeculae to replace most of the native TnC, and the
orientation of each probe was measured by polarized fluores-
cence (26) (SI Appendix, Table S1). The peak angle θME and SD
σME of the probe orientation distribution with respect to the
filament or trabecular axis under standard relaxing and activat-
ing conditions (SI Appendix, Table S2) were similar to values
reported previously (26). When trabeculae were activated by
50 μmol/L C1mC2 in the absence of Ca2+, θME for the TnC C-helix
probe (BR-TnC-C) increased over a period of 10–20 min as
C1mC2 diffused into the trabeculae and active force developed
(SI Appendix, Fig. S5). The increase in θME was 81 ± 4% (mean ±
SEM; n = 5) of the difference between its values in standard
relaxing and activating solutions (Fig. 2A, green and red dashed
lines), slightly larger than the corresponding fraction for active
force in these experiments (T/T0, 63 ± 8%). Transfer to normal
activating solution in the presence of C1mC2 (ACT C1mC2)
produced a further small increase in θME without a further in-
crease in force (T/T0 was 59 ± 8%). All these changes were fully
reversed by sequential washout of C1mC2 and calcium (SI Ap-
pendix, Fig. S5). The orientation changes of the BR-TnC-C
probe induced by addition of C1mC2 were almost independent
of the presence of 25 μmol/L blebbistatin (Fig. 2A; SI Appendix,
Table S2), which completely abolished active force (SI Appendix,
Fig. S5). Thus, the changes in TnC orientation induced by
C1mC2 are not mediated by force-generating myosin heads,
Fig. 1. Sarcomere location and domain architecture of MyBP-C. (A) C-zone
(green) of the thick filament in relation to its proximal (P) and distal (D)
regions and the thin filament (gray). (B) Cartoon representation of MyBP-C
(green) anchored to the thick filament backbone (purple) via its C-terminal
domains; myosin heads are pink and troponin is yellow. (C) Domain orga-
nization and interactions of MyBP-C.
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suggesting that C1mC2 has a direct effect on the structure of the
thin filament that mimics that produced by binding of Ca2+.
Similar results were obtained with the BR-TnC-E probe on the
IT arm of troponin (Fig. 2B; SI Appendix, Table S2), except that
the orientation changes induced by 50 μmol/L C1mC2 were
larger than those produced by maximal calcium activation.
Slightly smaller increases in θME for the E-helix probe were
observed in the presence of blebbistatin (Fig. 2B), but the change
in θME induced by C1mC2 in the presence of blebbistatin was
more than twice as large as that produced by calcium activation
under the same conditions.
C1mC2 Induced Changes in Myosin RLC Orientation. To investigate
the role of structural changes in the thick filaments during ac-
tivation by C1mC2, we used bifunctional sulphorhodamine
(BSR) probes on the RLC region of myosin, either cross-linking
RLC helices B and C (BSR-RLC-BC), roughly parallel to the
short hook helix of the myosin heavy chain at the C terminus of
the head domain, or along its E-helix (BSR-RLC-E), roughly
parallel to the lever arm of the head.
When trabeculae were activated by 50 μmol/L C1mC2 in the
absence of calcium, θME for both BSR-RLC-BC (Fig. 3A; SI
Appendix, Fig. S6) and BSR-RLC-E (Fig. 3B) changed from their
respective relaxed values (green dashed lines) toward values for
calcium activation (red dashed lines). The average changes in
θME induced by 50 μmol/L C1mC2 were 63 ± 4% and 43 ± 11%
(mean ± SEM; n = 5–7) of those associated with maximum
calcium activation for BSR-RLC-BC and BSR-RLC-E, re-
spectively (SI Appendix, Table S2), which is close to the corre-
sponding fractions for active force of 52 ± 4% and 42 ± 3%. No
further changes in θME were produced by calcium activation in
the presence of 50 μmol/L C1mC2 (SI Appendix, Fig. S7).
Blebbistatin had a direct effect on the structure of the thick
filament in the absence of calcium (Fig. 3; SI Appendix, Table
S2), signaled by a change in θME for both BSR-RLC-BC and
BSR-RLC-E from the values in standard relaxing solution in the
opposite direction to that produced by calcium activation. This
effect of blebbistatin on thick filament structure is consistent with
previous results from skeletal muscle showing that it stabilizes the
switch-2 closed state of the myosin head and the helical order of
myosin filaments (31, 32) associated with the asymmetric “J-motif”
seen in electron-microscopy reconstructions of isolated thick fila-
ments from both skeletal and cardiac muscles (8, 33). This more
ordered state of the thick filament is expected to inhibit the in-
teraction of the myosin heads with thin filaments; i.e., it is a more
OFF state of the thick filament.
Addition of calcium in the presence of blebbistatin produced
no significant change in θME for the RLC probes (Fig. 3; SI
Appendix, Table S2), suggesting that the thick filaments remain in
the OFF state. Addition of C1mC2 in the presence of blebbistatin
produced no significant change in θME for BSR-RLC-E (Fig. 3B),
but a further small increase in θME for BSR-RLC-BC (Fig.
3A), i.e., a further change in RLC orientation in the direction
associated with the OFF state of the thick filament. These RLC
probe experiments therefore suggest that C1mC2, like blebbis-
tatin, stabilizes the OFF structure of the thick filament and
inhibits contractility, in contrast to the activating effect of
C1mC2 on the structure of the thin filament.
Addition of 50 μmol/L tris-phosphorylated C1mC2 in relaxing
solution had no effect on the orientation of either the BSR-RLC-
BC or the BR-TnC-E probe (SI Appendix, Fig. S8), as expected
from the absence of force activation by this fragment.
Low Concentrations of C1mC2 Alter the Calcium Dependence of Thin
Filament Activation. Concentrations of N-terminal fragments of
MyBP-C that are too low to activate cardiac muscle in the ab-
sence of calcium increase the sensitivity and decrease the
cooperativity of the force–calcium relationship (23, 25, 34). We
used the TnC E-helix probe to investigate the structural basis of
these effects in the presence of 2 μmol/L C1mC2, a concentra-
tion that did not alter active force in either relaxing or activating
solution. This concentration of C1mC2 increased the pCa for
half-maximal force, pCa50, by about 0.25 pCa units (Fig. 4A; SI
Appendix, Table S3), indicating a significant increase in calcium
sensitivity, and the steepness of the force–pCa relationship, de-
scribed by the Hill coefficient (nH), decreased from 5.0 ± 0.2 to
2.4 ± 0.2. The net effect is a large increase in active force at
calcium concentrations in the physiological range; at pCa 5.7, for
example, active force increased from 3 to 50% of its maximum
value. C1mC2 (2 μmol/L) had no effect on the orientation of the
E-helix of TnC in the absence of calcium (Fig. 4B), but signifi-
cantly increased θME for the BR-TnC E-helix probe for all cal-
cium concentrations at which active force was generated. The
increase in pCa50 and the decrease in the Hill coefficient (nH) of
θME for BR-TnC-E induced by 2 μmol/L C1mC2 were similar to
those for active force (SI Appendix, Table S3).
When active force was abolished by 25 μmol/L blebbistatin,
the increase in θME for BR-TnC-E induced by calcium was re-
duced at all calcium concentrations (Fig. 4C, filled circles). In
addition, the calcium sensitivity of θME decreased (as measured
by pCa50) (SI Appendix, Table S3), and the steepness of the
calcium dependence, measured by the Hill coefficient nH, also
decreased. Addition of 2 μmol/L C1mC2 in the presence of
blebbistatin (Fig. 4C, open circles) reversed the decrease in θME
produced by blebbistatin at high [Ca2+] and increased pCa50 by
0.22 pCa units (Fig. 4C; SI Appendix, Table S3). However, the
steepness of the relationship between θME and [Ca2+] remained
low; in the presence of 2 μmol/L C1mC2, nH was about 2.5 and
roughly independent of force inhibition by blebbistatin. The in-
terpretation of these results is considered in Discussion.
Low Concentrations of C1mC2 Alter the Calcium Dependence of Thick
Filament Activation. The calcium dependence of the orientation of
RLC probes in cardiac trabeculae has not been reported pre-
viously. In the absence of C1mC2, θME for the BSR-RLC-BC
Fig. 2. Orientation (θME) of BR-TnC-C (A) and BR-TnC-E (B) probes in relax-
ing (REL) and activating solution (ACT) and the effects of 50 μmol/L C1mC2
and 25 μmol/L blebbistatin. Means ± SEM (n = 5–7). Statistical significance of
differences between values was assessed using a two-tailed paired Student’s
t test: *P < 0.05; †P < 0.01; ‡P < 0.001.
Fig. 3. Orientation (θME) of BSR-RLC-BC (A) and BSR-RLC-E (B) probes in
relaxing (REL) and activating solution (ACT) and the effects of 50 μmol/L
C1mC2 and 25 μmol/L blebbistatin. Means ± SEM (n = 5–7). Statistical sig-
nificance of differences between values was assessed using a two-tailed
paired Student’s t test: *P < 0.05; †P < 0.01.
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probe showed a biphasic dependence on calcium concentration
(Fig. 5B, filled circles), increasing between pCa 9 and 6 before
decreasing steeply between pCa 6 and 5.4, with nH = 8.4 ± 1.0 in
this range (SI Appendix, Table S3), compared with 5.5 ± 1.0 for
force. The origin of the change in RLC orientation in the pCa
range 9–6 is unknown.
Addition of 2 μmol/L C1mC2 increased pCa50 for force by 0.28 ±
0.02 pCa units (mean ± SE, n = 5) and decreased nH for force to
3.0 ± 0.2 in these trabeculae (Fig. 5A), similar to the results
described above for the TnC E-helix probe. It also abolished the
biphasic response of θME for the BSR-RLC-BC probe (Fig. 5B,
open circles), so that the θME data for this probe were well de-
scribed by the Hill equation with pCa50 = 5.97 ± 0.03 and nH =
3.2 ± 0.2 (SI Appendix, Table S3). pCa50 for θME remained sig-
nificantly higher than that for force, but the steepness of the
θME–pCa relationship was similar to that of force in the presence
of 2 μmol/L C1mC2, with nH close to 3, as reported above for
the TnC probes.
Discussion
MyBP-C C1mC2 Directly Activates the Thin Filament.The results from
the TnC probes reported above provide strong evidence that
N-terminal domains of MyBP-C bind to thin filaments in the
intact sarcomere of a heart muscle cell and induce a structural
change that mimics or exceeds that associated with normal cal-
cium activation. The stabilization of the ON structure of the thin
filament induced by 50 μmol/L C1mC2 in the absence of calcium
was still present when active force generation was inhibited by
blebbistatin. The latter observation makes it highly unlikely that
the activating effect of C1mC2 on the thin filament is a second-
ary effect of binding of myosin heads to the thin filament. Strong
binding of myosin heads to thin filaments is blocked by blebbistatin;
and weak binding, which may not be blocked by blebbistatin, is
almost independent of calcium and does not activate the thin fil-
ament (35). Moreover, the amplitude and kinetics of the calcium-
induced changes in the orientation of the analogous C- and E-helix
probes on TnC in skeletal muscle when active force is inhibited
by N-benzyl-p-toluenesulphonamide, which has similar effects to
blebbistatin, are the same as those produced when myosin binding
to actin is completely abolished by removing overlap between thin
and thick filaments (29). We conclude that the results of the
blebbistatin experiments reported here exclude the possibility that
changes in thin filament structure induced by C1mC2 are a sec-
ondary consequence of its effects on the thick filament.
These effects of C1mC2 on thin filament structure in the absence
of calcium are of the same size as those produced by binding of
myosin heads in the absence of MgATP (in rigor), as reported by
the same TnC probes. The average increases in θME for BR-TnC-C
and BR-TnC-E induced by 50 μmol/L C1mC2 were 2.8° and 7.3°,
respectively (SI Appendix, Table S2), which are very close to the
corresponding values of the analogous parameter θf for the changes
induced by myosin heads binding in rigor in the absence of calcium,
2.5° and 8.1°, respectively (26). The comparison suggests that in the
intact sarcomere C1mC2, like myosin heads in rigor, can displace
tropomyosin azimuthally around the thin filament toward the ON
position in which it would not interfere with myosin binding, as
observed in isolated thin filaments (36).
A much lower concentration of C1mC2, 2 μmol/L, was suffi-
cient to increase the level of thin filament activation significantly
at calcium concentrations in the physiological range (Fig. 4). The
activating effects of 2 μmol/L C1mC2 and calcium are synergis-
tic; the N-terminal region of MyBP-C renders the thin filament
more sensitive to calcium, and this leads to a large increase in
active force around pCa 5.8. The effects of low concentrations of
Fig. 4. Calcium dependence of force and TnC E-helix probe orientation in the absence (filled circles) and presence (open circles) of 2 μmol/L C1mC2. (A)
Force–pCa relation. (B and C): θME for BR-TnC-E in the absence (B) and the presence (C) of 25 μmol/L blebbistatin. Means ± SEM (n = 5).
Fig. 5. Calcium dependence of force and RLC BC-helix probe orientation in
the absence (filled circles) and the presence (open circles) of 2 μmol/L C1mC2.
(A) Force–pCa relation. (B) θME for BSR-RLC-BC. Means ± SEM (n = 5).
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C1mC2 were still present when active force was abolished by
blebbistatin, showing that they are not mediated by binding of
myosin heads; the synergistic effects of C1mC2 and calcium
operate at the level of the thin filament. Low concentrations of
C1mC2 also reduced the steepness of the calcium dependence at
the level of both the orientation change of the TnC E-helix and
the active force (Fig. 4; SI Appendix, Table S3); the Hill coefficient
nH was about 2.5, independent of the presence of blebbistatin.
Thus, C1mC2, like blebbistatin, reduces the cooperativity of cal-
cium activation, suggesting that the effects of both C1mC2 and
blebbistatin are mediated by stabilization of the OFF structure of
the thick filament (31). The residual cooperativity of calcium ac-
tivation under these conditions, corresponding to an nH of around
2.5, is likely to be an intrinsic property of the thin filament (26, 37),
whereas the higher nH value around 5 under control conditions
may be due to the additional contribution of thick filament-based
cooperativity, as discussed below.
MyBP-C C1mC2 Inhibits the Thick Filament. At calcium concen-
trations producing maximal activation, isometric force in the
presence of 50 μmol/L C1mC2 was about 60% of that in its
absence. C1mC2 therefore inhibits active force under these
conditions, despite its activating effect on the structure of the
thin filament. The comparison suggests that the inhibitory effect
of C1mC2 is mediated by a direct effect of C1mC2 on myosin
and the thick filament. This conclusion is supported by the
finding that changes in the orientation of the RLC probes in-
duced by 50 μmol/L C1mC2 in either the absence or the presence
of calcium were about 60% of those produced by normal calcium
activation (Fig. 3; SI Appendix, Fig. S7), consistent with the 60%
active force produced under these conditions, but less than the
corresponding percentage for the orientation change of the TnC
probes (Fig. 2). Moreover, the changes in the orientation of the
RLC probes induced by C1mC2 were either abolished or re-
versed by blebbistatin (Fig. 3), again in marked contrast to the
results from the TnC probes. Taken together, these results suggest
that C1mC2 inhibits contractility by stabilizing the OFF structure
of the thick filament, although an alternative inhibitory mecha-
nism involving direct competition between C1mC2 and myosin for
actin-binding sites cannot be excluded by the present results.
A much lower concentration of C1mC2, 2 μmol/L, did not
inhibit force or the orientation change of the RLC BC-helix
probe at maximal [Ca2+], but decreased the steepness of the
calcium dependence of the orientation change. The Hill co-
efficient (nH) for the RLC orientation change was about 3,
similar to that of BR-TnC-E and of active force under the same
conditions. The abolition of the biphasic calcium dependence of
BSR-RLC-BC orientation and of its very steep slope in the range
pCa 6.0–5.4 (Fig. 5) by this low concentration of C1mC2 suggests
that these effects may be mediated by native MyBP-C molecules
in the C-zone, as discussed further below.
Inferring the Function of Native MyBP-C from the Effects of MyBP-C
Fragments. The use of MyBP-C fragments as a model system to
investigate the function of native MyBP-C has significant limi-
tations. Native MyBP-C is confined to nine stripes at 43-nm
intervals in the C-zone in the central third of each half-thick
filament (Fig. 1A). Within the C-zone, there are three molecules
of MyBP-C per 43-nm length of thick filament (38), corre-
sponding to a 1:6 ratio of MyBP-C to myosin heads, or roughly
1:12 MyBP-C:actin monomers. MyBP-C fragments are not sub-
ject to these stoichiometric limitations and could in principle
bind to every actin or every myosin molecule in the sarcomere.
The concentrations of C1mC2 used in the present experiments
are similar to or lower than the native concentrations in skinned
trabeculae. The d10 spacing of the thick filament lattice planes is
about 46 nm in this preparation (39), so the volume of a unit cell
corresponding to the 43-nm repeat of a thick filament is 43 ×
46 × 46 × 2/√3 nm3, giving a local MyBP-C concentration of
∼50 μmol/L. This is higher than the C1mC2 concentration re-
quired for half-maximum activation in the absence of calcium, 20
μmol/L, and much higher than the 2 μmol/L that produced sub-
stantial effects on thin and thick filament structure at physiological
calcium concentrations (Figs. 4 and 5). The effects of competition
between exogenous MyBP-C fragments and native full-length
MyBP-C are likely to be small in these experiments for two rea-
sons: the high stoichiometry of exogenous fragments to native
MyBP-C and the fact that the native MyBP-C is phosphorylated
at ∼2 mol Pi/mol MyBP-C under the conditions of the present
experiments (SI Appendix, Fig. S1), which is expected to inhibit its
interactions with both myosin S2 and actin (5, 14). The finding
that the effects of exogenous C1mC2 fragments are still present
in MyBP-C knockout mice (22) also argues strongly against a sig-
nificant role for competition with native MyBP-C.
The present results provide further evidence that the MyBP-C
fragments are a useful model for studying the function of the
full-length protein, particularly in the case of the activating effect
on thin filaments, which has been controversial (15). The frag-
ments have substantial activating effects at a concentration of
2 μmol/L (Fig. 4), much lower than the native concentration of
MyBP-C in the C-zone, and activating effects dominate in-
hibitory effects under those conditions (Figs. 4 and 5). The
similarity of the structural changes in the thin filament produced
by C1mC2, by calcium and by binding of myosin heads also
argues against the activating effect being purely an artifact, as do
its abolition by phosphorylation and the sequence and species
specificity of the effects (22, 25, 27).
Role of MyBP-C in the Regulation of Cardiac Contractility. The above
results, together with those of a wide range of previous studies
referenced in the Introduction and recent reviews (15, 16, 21),
suggest the following working hypotheses for the function of
native MyBP-C:
i) The N-terminal region of MyBP-C binds to thin and thick
filaments with about the same affinity (10, 14).
ii) Binding of the N-terminal region of MyBP-C to thin filaments
stabilizes their ON state.
iii) Binding of the N-terminal region of MyBP-C to thick fila-
ments stabilizes their ordered OFF state.
iv) These effects are transmitted along both thin and thick fil-
aments by cooperative transitions in filament structure.
In relation to number iv, the concept of cooperative trans-
mission of activation state along thin filaments, mediated by end-
to-end interactions between tropomyosins in adjacent regulatory
units, is well established (2). Cooperative structural transitions in
the thick filaments from both skeletal and cardiac muscle are
implied by intermolecular interactions between myosin heads in
the OFF state (8, 9, 33).
According to this working hypothesis, the structures of the thin
and thick filaments at diastole might be as diagrammed in Fig.
6A. Some of the MyBP-C molecules (green) in the C-zone are
Fig. 6. Proposed role of MyBP-C in cardiac muscle regulation. (A–C) Pro-
gressively increasing calcium concentrations, corresponding to pCa 6.0, 5.8,
and 5.4 under the conditions of our experiments. Colors are as in Fig. 1B
except that orange and red troponins denote increased activation state,
calcium is green, and myosin heads are light brown in the ordered OFF state
and dark brown in the ON state.
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bound to myosin S2 via their N-terminal domains, stabilizing the
ordered OFF state of the thick filaments in which myosin heads
(light brown) are folded back against the filament surface. The
N-terminal regions of other MyBP-Cs are bound to thin filaments
(gray), increasing the calcium sensitivity of regulatory units in the
C-zone. However, the whole thin filament remains OFF, as
denoted by the yellow troponins, as a result of the dominant
effect of the roughly three-quarters of regulatory units outside
the C-zone that are not calcium-sensitized. The whole thick fil-
ament is also OFF. At a slightly higher Ca2+ concentration (Fig.
6B), the region of the thin filament opposite the C-zone starts to
become activated whereas the rest of the thin filament remains
OFF. As a result, myosin heads in the C-zone bind to actin, and
fewer MyBP-Cs may be bound to the thin filament as a result of
displacement by myosin heads or because tropomyosin competes
with their actin-binding sites. A combination of structural
changes in MyBP-C and myosin heads in the C-zone leads to
local activation of the thick filament as myosin heads leave the
folded OFF state, and this structural change is propagated along
the thick filament by its longitudinal cooperativity. As [Ca2+]
increases further (Fig. 6C), these effects are amplified, and the
P- and D-zones of the sarcomere are progressively recruited and
contribute to maximal active force. However, the inhibitory ef-
fect of MyBP-C on the thick filament is still present (SI Appen-
dix, Fig. S7), allowing the ON state of the thick filament to be
modulated by physiological control of the level of MyBP-C
phosphorylation at levels intermediate between the tris-phos-
phorylated state at which its inhibition is undetectable and the
dephosphorylated state at which it is maximal.
According to this hypothesis, one function of the C-zone may
be to enable graded rather than uniform activation of the muscle
sarcomere; myosin heads may be recruited at higher [Ca2+] be-
cause the length of the active region of the filaments increases.
This effect might contribute to length-dependent regulation and
the Frank–Starling relation (15). The C-zone may also act as
a sarcomeric signaling element that transmits the activation signal
from the thin to the thick filaments, with cooperativity in both the
thin and thick filaments subsequently transmitting the activation
signal along the sarcomere from the C- to the P- and D-zones.
Finally, thick filament cooperativity could make a contribution to
the steep [Ca2+] dependence of contractility similar to that of the
thin filaments. In this holistic view of the regulation of cardiac
contractility, the effective regulatory unit in heart muscle is the
sarcomere itself, and mutations in the sarcomeric proteins linked
to hypertrophic cardiomyopathy have a common mechanistic
target, providing an integrated framework for the design and
development of therapeutic interventions in heart disease.
Materials and Methods
Protein production, preparation of cardiac trabeculae, protein exchange
protocols, and fluorescence polarization experiments were performed
according to routine protocols published elsewhere. Details of materials and
methods are provided in SI Appendix.
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